4 Dec

Cooper Companies’ Income Rose in Fiscal 4Q15

WRITTEN BY Gabriel Kane

Cooper’s price movement

Cooper Companies (COO) has a market cap of $6.9 billion. Its YTD (year-to-date) price movement was a mix of rises and falls in fiscal 2015. After the fiscal 4Q15 earnings report, COO fell by 4.9% to close at $142.05 per share as of December 3, 2015. The price movement on a weekly, monthly, and YTD basis is -2.2%, -6.6%, and -12.3%, respectively.

Cooper Companies’ Income Rose in Fiscal 4Q15

Currently, Cooper is trading 4.0% below its 20-day moving average, 3.4% below its 50-day moving average, and 15.4% below its 200-day moving average.

The SPDR S&P Health Care Equipment ETF (XHE) invests 1.9% of its holdings in Cooper. The ETF tracks an equal-weighted index of US health care equipment and supplies companies. The YTD price movement of XHE is 10.6% as of December 2, 2015. The SPDR S&P 400 Mid-Cap Growth ETF (MDYG) invests 1.0% of its holdings in Cooper.

The competitors of Cooper Companies (COO) and their market caps are:

  • Johnson & Johnson (JNJ) — $278.9 billion
  • Boston Scientific (BSX) — $24.3 billion
  • Hologic (HOLX) — $11.1 billion

Performance of Cooper Companies in fiscal 4Q15 and fiscal 2015

Cooper reported fiscal 4Q15 net sales of $455.5 million, a fall of 2.7% when compared to net sales of $468.0 million in fiscal 4Q14. The company’s cost of sales as a percentage of sales rose by 10.0% while its gross profit margin fell by 6.8% in fiscal 4Q15 as compared to the prior year period.

Net income and EPS (earnings per share) rose to $36.7 million and $0.75, respectively, in fiscal 4Q15, as compared to net income and EPS of $30.8 million and $0.63, respectively, in fiscal 4Q14. Cooper’s non-GAAP (generally accepted accounting principles) EPS rose to $2.00 in fiscal 4Q15, a rise of 2.6% as compared to the prior year period.

On August 10, 2015, Cooper Surgical, a unit of Cooper Companies, acquired Reprogenetics. This acquisition is valued at ~$46.5 million and is expected to be neutral to fiscal 2015 and 2016 EPS and accretive after that, excluding one-time charges and deal-related amortization.

In October 2015, the company repurchased $51.3 million of common stock under its share repurchase program for an average share price of $139.6.

Fiscal 2015 results

In fiscal 2015, the company reported net sales of $1,797.1 million, a rise of 4.6% YoY (year-over-year). The company’s gross profit margin and operating income fell by 6.3% and 22.8%, respectively, in fiscal 2015.

Also, its net income and EPS fell to $203.5 million and $4.14, respectively, in fiscal 2015, as compared to net income and EPS of $269.9 million and $5.51, respectively, in fiscal 2014. Its non-GAAP EPS rose to $7.44 in fiscal 2015, a rise of 2.1% YoY.

Meanwhile, Cooper’s cash and cash equivalents fell by 34.9% while its inventories rose by 10.0%. The company’s current ratio and debt-to-equity ratio fell to 1.5 and 0.66, respectively, in fiscal 2015, as compared to a current ratio of 1.8 and a debt-to-equity ratio of 0.72 in fiscal 2014. It reported an adjusted free cash flow of $216.4 million in fiscal 2015.

Projections

The company has projected the following for fiscal 1Q16:

  • total revenue in the range of $435.0 to $447.0 million
  • non-GAAP EPS in the range of $1.52 to $1.62

Additionally, Cooper expects the following for fiscal 2016:

  • total revenue in the range of $1,834.0 to $1,874.0 million
  • non-GAAP EPS in the range of $7.60 to $7.90

Non-GAAP EPS represents pro forma growth of 10% to 14%, including the forecast negative impact from foreign currency of $0.58 per share for fiscal 2016.

Latest articles

US crude oil production has more than doubled since 2009 and grew by 1.1% over the last year. Currently, there are 133 operable refineries in the US.

The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.

Higher revenues, increased ticket prices, and lower fuel costs are likely to drive American Airlines' Q3 earnings higher despite its Boeing MAX woes.

HEXO plans to report its Q4 earnings before the market opens on October 24. October has been tough for Hexo, with its stock falling 31.2% as of October 18.

Today, Advanced Micro Devices (AMD) rose 4% to over $32, making it one of the top Nasdaq gainers. Morgan Stanley raised its price target for AMD stock.

Early in 2019, President Donald Trump warned that China could overtake the US as a global power. He vowed that this would not happen under his leadership.